Drugs / BCG
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07064863 Comparator | Aug 2025 → Jul 2027 expected | non-invasive bladder urothelial carcinoma | Queen's University | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BCG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07064863 ↗ |
| Route | Other | “intravesical BCG (50 mg, TICE strain)” NCT07064863 ↗ |